Want to join the conversation?
For FY17, $UNFI expects net sales to be in the range of approx. $9.43-9.60Bil, an increase of 11.3-13.3% over FY16 net sales. The company anticipates GAAP diluted EPS to be in the range of approx. $2.53-2.63, up approx. 1.2-5.2% over FY16 diluted EPS of $2.50. CapEx for FY17 is expected to be $55-80MM, or approx. 0.6-0.8% of anticipated net sales.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?